View on market: Volatility Prevails, Market is searching for better value
After a selloff in American equities and bonds in response to hawkish remarks in the minutes of the Federal Reserve’s most recent meeting, shares in Asia are set to tumble. Benchmark equity futures for Japan, Australia, and Hong Kong all fell. Wednesday saw a 0.8% decline in the S&P 500 and a 1.1% decline in the Nasdaq 100, with heavyweights Tesla Inc., Amazon.com Inc., and Meta Platforms Inc. each falling more than 1.5%. Early Asian trade saw no change in US futures. West Texas Intermediate was trading below $80 a barrel, while Brent crude was trading around $84. A 10-year US bond’s yield was 4.25%, while the price of Bitcoin was below the 29,000 mark. At 5:25 a.m., the GIFT Nifty, an early indicator of the Nifty 50 Index’s performance in India was unchanged at 19,574.5 points.
Economic Calendar:
- USD : Initial Jobless Claims on 17th Aug, 2023
- USD : Philadelphia Fed Manufacturing Index (Aug) on 17th Aug, 2023
- INR : FX Reserves, USD on 18th Aug, 2023
- INR : GDP Quarterly (YoY) (Q1) on 31st Aug, 2023
Brokerage Radar:
JEFFERIES ON JK CEMENT: Hold, TP Rs 3310; Reported a stable EBITDA performance for 1Q driven by strong vols offsetting pricing weakness. Blended SA EBITDA/t at Rs890 improved Rs96 QoQ driven by costs easing.; Mgt commentary indicates +ve trend for pricing in 2Q
MS ON NBFCs: Valuations Are Reasonable To Attractive For Most Lenders; Overweight on Bajaj Fin, Target Rs 9,500; Overweight on Can Fin, Target Rs 1,000
Overweight on SBI Card, Target Rs 1,155; Overweight on Aptus Value, Target Rs 268
Overweight on Shriram Finance, Target Rs 2,200; Overweight on Home First, Target Rs 1,050; Equal-weight on LIC Housing, Target Rs 450; Equal-weight on M&M Fin, Target Rs 300; Equal-weight on Chola Invest, Target Rs 1,000; Underweight on L&T Finance, Target Rs 110
CLSA ON VODA IDEA: Sell, TP Rs 7; 1Q revenue up 1% QoQ to Rs106bn, below est.
Ebitda down 2% QoQ while net loss up 22% QoQ; ARPU was up 3% QoQ and VIdea has followed Bharti’s entry tariff hike; Has sought 30 days grace to pay a 5G spectrum instalment
International Markets
U.S & Europe:
Particulars | 16th August | Chg. | Chg.(%) |
Nasdaq | 13474.63 | -156.42 | -1.15 |
Dow | 34765.74 | -180.65 | -0.52 |
FTSE | 7356.88 | -32.76 | -0.45 |
CAC | 7260.25 | -7.45 | -0.10 |
DAX | 15789.45 | 22.17 | 0.14 |
Dow Fut.* | 34776.10 | 10.40 | 0.03 |
Asian markets:
Particulars | 17th August | Chg. | Chg.(%) |
GIFT Nifty | 19405.50 | -6.50 | -0.03 |
Nikkei | 31478.90 | -287.92 | -0.91 |
Straits Times | 3194.94 | -18.64 | -0.58 |
Hang Seng | 18173.53 | -155.77 | -0.85 |
Shanghai | 3142.45 | -7.68 | -0.24 |
ADR Watch:
Particulars | 16th August | Chg. | Chg.(%) |
Dr. Reddy | 71.00 | -0.07 | -0.10 |
HDFC Bank | 63.57 | -0.29 | -0.45 |
ICICI Bank | 22.93 | 0.11 | 0.48 |
Infosys | 17.13 | 0.00 | 0.00 |
Wipro | 5.00 | 0.02 | 0.40 |
Commodities & Currency:
Particulars | Current Price | Chg.(%) |
USD/INR | 83.18 | -0.10 |
Brent | 83.59 | 0.17 |
Gold | 1923.15 | -0.27 |
Silver | 22.505 | -0.13 |
FIIs & DIIs:
Particulars | 16th August | 14th August |
FIIs | 722.76 | -2324.23 |
DIIs | 2406.19 | 1460.90 |
News Update:
Lupin: The drugmaker announced the launch of ‘Jeet’, its patient support program dedicated to heart-health. It also launched Tiotropium Dry Powder for inhaler for the treatment of chronic obstructive pulmonary disease in the U.S.
Aurobindo Pharma: The drugmaker will launch HIV triple combination product for children living with HIV in low-and middle-income countries under voluntary license from ViiV Healthcare.
Powergrid: The company’s assets under ‘North Eastern Region Strengthening Scheme-VI’ have received notification for commercial operation on Aug. 16.
One97 Communications: Chinese e-commerce major Alibaba group firm Antfin has transferred its 10.3% stake to the fintech firm’s founder and CEO Vijay Shekhar Sharma. The deal turns Paytm into a majorly Indian-owned company from being majorly owned by Chinese entities.
Cipla: The company received an order of suspension of FDA license issued to its manufacturing unit in Patalganga, Maharashtra for 10 days in December for non-conformance of good manufacturing practices. The company is in the process of appealing the order to the state government.
Nava: The company suspended silico manganese production at its Odisha plant after failure of raw material feeding infrastructure.
Adani Power: Goldman Sachs Trust II-Goldman Sachs GQG Partners International Opportunities Fund has bought 10.3 crore equity shares in Adani Group company and GQG Partners Emerging Markets Equity Fund purchased 4.9 crore shares from open market transactions, at an average price of Rs 279.15 per share, which is equivalent to 3.94% of total equity and amounted to Rs 4,244.76 crore. However, promoters Worldwide Emerging Market Holding Limited sold 4.65 crore shares in Adani Power at an average price of Rs 279.16 per share, and Afro Asia Trade and Investments offloaded 26.54 crore shares at an average price of Rs 279.18 per share.
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
- Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.